Breast cancer treatment: Drug Kisqali approval expanded for ... - NBC News
网页2 天之前 · The drug was found to reduce the risk of a patient's breast cancer coming back by 25%. The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to ...
3D mammography better at detecting early-stage cancer with ... - ABC News
网页2 天之前 · The study, which analyzed more than 272,000 breast cancer screenings over 13 years, showed that 3D mammography, known as digital breast tomosynthesis, or DBT, identified breast cancer at higher ...
New study finds triple-negative breast cancer tumors with an …
网页2024年4月25日 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Breast Cancer News - ScienceDaily
网页4 天之前 · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
Estrogen a more powerful breast cancer culprit than we realized
网页2023年5月17日 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast cancer metastasis on/off switch revealed - Stanford News
网页December 20th, 2023 | 5 min read Science & Engineering. Researchers uncover on/off switch for breast cancer metastasis. New research from Stanford and the Arc Institute could lead to a new and more effective immunotherapy and help clinicians better predict patient response to existing medicines.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
网页2022年6月7日 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
网页2021年10月19日 · In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show.
Pembrolizumab for Advanced Triple-Negative Breast Cancer
网页2022年8月9日 · In the KEYNOTE-355 trial, 847 patients with advanced (unresectable, locally advanced, or metastatic) triple-negative breast cancer were randomly assigned to receive chemotherapy plus placebo or chemotherapy plus pembrolizumab.
Experimental immunotherapy targets metastatic breast cancer
网页2022年2月1日 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
- 某些结果已被删除